相关实验视频

Updated: Jul 5, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

评估毒素的有效性和生活质量在腹水症:一年的前性研究

Luca Castiglione^1,2, Marius Murariu², Estera Boeriu³

¹Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Diseases (Basel, Switzerland)

|January 22, 2024

概括

毒素 (Botox) 治疗显著减少下汗,并改善过症患者一年以上的生活质量. 这种有效的治疗为身体症状和心理社会福祉提供了长期的好处.

科学领域:

皮肤病学皮肤病学
医学美学医学美学
临床研究临床研究

背景情况:

腹过严重影响患者的生活质量.
对于一些超患者来说,传统治疗可能是无效的.
玻尿酸毒素 (Botox) 是一种潜在的治疗方法,可用于治疗超.

研究的目的:

评估长期有效性肉毒素 (Botox) 疗法在减少汗液产量在下腺过症患者超过一年.
评估博托克斯治疗对下腺透症患者各种生活质量方面的影响.

主要方法:

这是一项前性研究,涉及81名患有初级下腺透症的成年患者.
患者接受了毒素 (Botox) 注射.
评估包括量化汗液产量测量和生活质量评估 (HDSS,WHOQOL-BREF,DLQI) 在基线,六个月和一年.

主要成果:

在一年内,汗液产量从0.81g减少到0.23g每15分钟 (p < 0.001).
过症疾病严重程度量表 (HDSS) 的得分明显下降,从3.4降至1.5 (p < 0.001).
皮肤病生活质量指数 (DLQI) 的得分从19.9到6.9 (p < 0.001) 显著改善,在社会和环境生活质量领域取得了显著的收益.

结论:

毒素 (Botox) 疗法在一年的时间内为下腺胀患者提供持续减少汗水产生的疗法.
治疗显著提高了身体和心理社会生活质量领域.
博托克斯疗法是一种有效的长期治疗选择,用于管理腹透症.

关键词:

波托克斯 (Botox) 是一种治疗方法.过过症是一种超症.人们的生活质量.

更多相关视频

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

$MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor$ 05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

相关概念视频

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...